BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2015
View Archived Issues
Pfizer synthesizes new Abeta production inhibitors
Read More
Selective Nav1.7 inhibitors for the treatment of pain
Read More
IncellDx and Claremont to combine technologies for liquid-based biopsy system
Read More
JCR Pharma initiates development of ERT using BBB-crossing technology
Read More
Nanosyn and LLS update progress of MLL leukemia project
Read More
Piramal Enterprises presents BRD4 inhibitors
Read More
Sunshine Lake Pharma presents SGLT2 inhibitors
Read More
GDF15 may be a superior biomarker for mitochondrial disease diagnosis
Read More
Johnson & Johnson recaps highlights of first quarter 2015
Read More
Ombitasvir/paritaprevir/ritonavir HCV combination granted priority review in Japan
Read More
Avelas starts phase I trial of real-time fluorescent illuminator for breast cancer surgery
Read More
Baxter files for approval of BAX-855 in Japan
Read More
Isarna Therapeutics initiates first-in-human trial of ISTH-0036
Read More
Receptos's ozanimod achieves efficacy endpoints in phase II ulcerative colitis trial
Read More
TC-6499 fails to reduce gastric emptying time in diabetic gastroparesis study
Read More
Tipelukast receives FDA fast track designation for NASH with fibrosis
Read More
Actelion updates on clinical development of S1P1 receptor modulators
Read More
Discovery Laboratories advances development of Aerosurf, ceases commercialization of Surfaxin
Read More
World Hemophilia Day: Hyperfunctional FIX as a promising tool in hemophilia
Read More
Anacor reports boron-containing PDE4 inhibitors
Read More
Merck & Co. develops Trk-A inhibitors
Read More
FDA grants orphan drug designation to selumetinib for uveal melanoma
Read More
Chugai presents anti-protein-C MAbs
Read More
Provectus initiates phase III trial of PV-10 in melanoma
Read More
Genmab achieves fifth milestone in daratumumab collaboration with Janssen Biotech
Read More